Goldstein Michael H.

Chief Medical Officer at APPLIED GENETIC TECHNOLOGIES CORP · on record since Dec 2, 2016
President, Ophthalmology & CMO at OCULAR THERAPEUTIX, INC · on record since Sep 27, 2017

Insider trading activity of Goldstein Michael H.

Transactions on record: 11; since Dec 2, 2016

Open-market buys: 2; $71.6K

Open-market sells: 0

Companies traded: 2; last filing Feb 7, 2022

Figures computed from official regulatory filings — .

Companies where Goldstein Michael H. has traded

OCULAR THERAPEUTIX, INC9 tx · $71.6K · Feb 7, 2022
APPLIED GENETIC TECHNOLOGIES CORP2 tx · Jul 18, 2017

Track record of Goldstein Michael H.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Goldstein Michael H.

Co-insiders of Goldstein Michael H.

PEACOCK BRUCEAPPLIED GENETIC TECHNOLOGIES CORP +1
Aliski WilliamAPPLIED GENETIC TECHNOLOGIES CORP
Alta Partners Management VIII, LLCAPPLIED GENETIC TECHNOLOGIES CORP
Alta Partners VIII, L.P.APPLIED GENETIC TECHNOLOGIES CORP
Anderman ToddOCULAR THERAPEUTIX, INC
Ankerud EricOCULAR THERAPEUTIX, INC
Ascension Health Ventures II, LLCOCULAR THERAPEUTIX, INC
Ashe Andrew D.APPLIED GENETIC TECHNOLOGIES CORP
Bollag Daniel MOCULAR THERAPEUTIX, INC
BULLOCK LAWRENCE EAPPLIED GENETIC TECHNOLOGIES CORP
Carroll JillAPPLIED GENETIC TECHNOLOGIES CORP
CASH HARVEY BAPPLIED GENETIC TECHNOLOGIES CORP
Chadha JaswinderOCULAR THERAPEUTIX, INC
CHAMPSI FARAHAPPLIED GENETIC TECHNOLOGIES CORP
Chulay Jeffrey D.APPLIED GENETIC TECHNOLOGIES CORP
CHV II, L.P.OCULAR THERAPEUTIX, INC
Crane Alan LOCULAR THERAPEUTIX, INC
DOyley-Gay HopeAPPLIED GENETIC TECHNOLOGIES CORP
Dugel PravinOCULAR THERAPEUTIX, INC
Feinsod MatthewAPPLIED GENETIC TECHNOLOGIES CORP
Fortune JamesOCULAR THERAPEUTIX, INC
GARVEY JAMES MOCULAR THERAPEUTIX, INC
GIANOS PHILIP TAPPLIED GENETIC TECHNOLOGIES CORP
GLAXOSMITHKLINE PLCAPPLIED GENETIC TECHNOLOGIES CORP

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
OCULAR THERAPEUTIX, INCListing on record	Feb 7, 2022	Award	63,333	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OCULAR THERAPEUTIX, INCListing on record	Feb 7, 2022	AwardD (derivative)	190,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OCULAR THERAPEUTIX, INCListing on record	Feb 19, 2021	AwardD (derivative)	250,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OCULAR THERAPEUTIX, INCListing on record	Feb 3, 2020	AwardD (derivative)	215,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OCULAR THERAPEUTIX, INCListing on record	May 30, 2019	Buy	12,000	2.51 USD	$30.1K	conv 80Cluster	SEC
OCULAR THERAPEUTIX, INCListing on record	Mar 18, 2019	Buy	10,000	4.15 USD	$41.5K	conv 89ClusterFirst in 12mo	SEC
OCULAR THERAPEUTIX, INCListing on record	Jan 4, 2019	AwardD (derivative)	150,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OCULAR THERAPEUTIX, INCListing on record	Feb 2, 2018	AwardD (derivative)	83,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OCULAR THERAPEUTIX, INCListing on record	Oct 3, 2017	AwardD (derivative)	135,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
APPLIED GENETIC TECHNOLOGIES CORPListing unverified	Jul 18, 2017	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
APPLIED GENETIC TECHNOLOGIES CORPListing unverified	Dec 2, 2016	AwardD (derivative)	180,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
OCULAR THERAPEUTIX, INCListing on record	Feb 7, 2022	Award	63,333	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OCULAR THERAPEUTIX, INCListing on record	Feb 7, 2022	AwardD (derivative)	190,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OCULAR THERAPEUTIX, INCListing on record	Feb 19, 2021	AwardD (derivative)	250,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OCULAR THERAPEUTIX, INCListing on record	Feb 3, 2020	AwardD (derivative)	215,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OCULAR THERAPEUTIX, INCListing on record	May 30, 2019	Buy	12,000	2.51 USD	$30.1K	conv 80Cluster	SEC
OCULAR THERAPEUTIX, INCListing on record	Mar 18, 2019	Buy	10,000	4.15 USD	$41.5K	conv 89ClusterFirst in 12mo	SEC
OCULAR THERAPEUTIX, INCListing on record	Jan 4, 2019	AwardD (derivative)	150,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OCULAR THERAPEUTIX, INCListing on record	Feb 2, 2018	AwardD (derivative)	83,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OCULAR THERAPEUTIX, INCListing on record	Oct 3, 2017	AwardD (derivative)	135,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
APPLIED GENETIC TECHNOLOGIES CORPListing unverified	Jul 18, 2017	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
APPLIED GENETIC TECHNOLOGIES CORPListing unverified	Dec 2, 2016	AwardD (derivative)	180,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC